AEON Biopharma, Inc.
AEONHealthcare|Biotechnology|US
$0.18
+0.02 (+11.26%)
Cash / Share
$0.07
Next Earnings Report
Nov 13, 2026
EPS est. -$0.10
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450
Sep 30, 2026 · GlobeNewsWire
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®
Sep 9, 2026 · GlobeNewsWire
AEON Biopharma to Participate in Lake Street Capital Markets' 10th Annual Best Ideas Growth (BIG10) Conference
Aug 31, 2026 · GlobeNewsWire
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
Aug 24, 2026 · GlobeNewsWire
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®
Aug 19, 2026 · GlobeNewsWire
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 12, 2026 · GlobeNewsWire